- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06311838
Building Social and Structural Connections for the Prevention of Opioid Use Disorder Among Youth Experiencing Homelessness
Building Social and Structural Connections for the Prevention of Opioid Use Disorder Among Youth Experiencing Homelessness: An RCT Examining Biopsychosocial Mechanisms
Study Overview
Status
Conditions
Detailed Description
Specific Aim 1. Using a dismantling randomized design, compare intervention conditions to determine those components essential for optimizing substance use and mental health: a) Strengths-Based Outreach and Advocacy (SBOA), b) Motivational Interviewing (MI)/Community Reinforcement Approach (CRA), c) SBOA+MI/CRA, and d) Services As Usual (SAU). Hypothesis. Youth assigned to SBOA+MI/CRA will show better short and long-term outcomes on Opioid Use Disorder prevention and on other substance use and mental health outcomes than youth assigned to either intervention alone or Services As Usual.
Specific Aim 2. Test whether intended change processes (social stability, psychosocial resources, stress) produce the desired change on substance use and mental health. Hypothesis. Inasmuch as the interventions trigger successful increases in social stability and psychosocial resources and reductions in stress, targeted outcomes will improve.
Specific Aim 3. Explore how the moderators of age, sex, race/ethnicity, sexual/gender minority status, and experience of childhood abuse and neglect influence intervention response.
Specific Aim 4. Determine cost effectiveness of the intervention approaches.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jodi Ford, PhD
- Phone Number: 614-292-6862
- Email: ford.553@osu.edu
Study Contact Backup
- Name: Natasha Slesnick, PhD
- Phone Number: (614) 247-8469
- Email: slesnick.5@osu.edu
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- Recruiting
- Ohio State University
-
Contact:
- Jodi Ford, PhD
- Phone Number: 614-292-6862
- Email: ford.553@osu.edu
-
Contact:
- Natasha Slesnick, PhD
- Phone Number: (614) 247-8469
- Email: slesnick.5@osu.edu
-
Principal Investigator:
- Jodi Ford, PhD
-
Principal Investigator:
- Natasha Slesnick, PhD
-
Columbus, Ohio, United States, 43201
- Recruiting
- Star House
-
Contact:
- Natasha Slesnick, PhD
- Phone Number: 614-247-8469
- Email: slesnick.5@osu.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Youth must meet the criteria for homelessness as defined by the McKinney-Vento Act: children and youth who lack a fixed, regular, and adequate nighttime residence; or live in a welfare hotel, or place without regular sleeping accommodations, or live in a shared residence with other persons due to the loss of one's housing or economic hardship
- Must speak english adequately to complete measures
Exclusion Criteria:
- Youth who have a stable housing situation.
- Non-English speaker
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Motivational Interviewing/Community Reinforcement Approach + Services as Usual (MI/CRA + SAU)
The current evidence base recommends integrating treatments targeting both Substance Use Disorder and psychiatric disorders, especially combining Motivational Interviewing with behavioral interventions such as CRA or Cognitive Behaviorial Therapy. Enhancing intrinsic motivation for behavioral change is the central purpose of motivational interviewing (MI), a clinical method built on the insights and strategies described by Carl Rogers as client-centered therapy. MI is also directive, however, in selectively eliciting and reinforcing client "change talk". Typically offered as a brief intervention of 1-2 sessions, MI has a strong record of efficacy in the treatment of alcohol and other drug use disorders, mental health and other problematic behaviors. The Community Reinforcement Approach (CRA) offers an empirically-based multifaceted approach to substance abuse/mental health treatment that also addresses many of the clinical needs of multi-problem homeless individuals. |
MI/CRA includes two Motivational Interviewing sessions and twelve 1-hour Community Reinforcement Approach sessions.
Participants assigned to this group will receive the standard services provided to all youth involved with the drop-in center.
|
|
Experimental: Strengths-Based Outreach and Advocacy + Services As Usual (SBOA +SAU)
Some research suggests that engagement with an advocate is key to success when linking those experiencing homelessness to available services and supports in the community.
The strengths model is based on the premise that the purpose of advocacy "is to assist consumers in identifying, securing, and preserving the range of resources, both external and internal, needed to live in a normal, independent way in the community".
Strengths-based interventions focus on enhancing well-being and happiness rather than attempting to correct deficits or pathology.
The advocate takes responsibility for securing needed services for the youth and remains a support as they traverse the system of care.
The focus of the first several weeks of advocacy is on obtaining identification and ensuring basic needs are met (food, safety, medical care, housing, etc.).
As basic needs are addressed, youth and advocates focus on other high need areas including education, employment, mental health and substance use.
|
Participants assigned to this group will receive the standard services provided to all youth involved with the drop-in center.
The number of Strengths-Based Outreach and Advocacy sessions participants will receive are flexibly determined based upon youth needs.
|
|
Experimental: Motivational Interviewing/Community Reinforcement Approach (MI/CRA) + SBOA + SAU
This intervention combines all three interventional models: Motivational Interviewing/Community Reinforcement Approach along with Strengths-Based Outreach and Advocacy and the Services as Usual.
|
MI/CRA includes two Motivational Interviewing sessions and twelve 1-hour Community Reinforcement Approach sessions.
Participants assigned to this group will receive the standard services provided to all youth involved with the drop-in center.
The number of Strengths-Based Outreach and Advocacy sessions participants will receive are flexibly determined based upon youth needs.
|
|
Active Comparator: Services as Usual (SAU)
All youth will receive services as usual provided by the drop-in center.
|
Participants assigned to this group will receive the standard services provided to all youth involved with the drop-in center.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Form 90 Substance Use interview
Time Frame: Administered at baseline, and 3-, 6-, and 12-, 18-, and 24-months post intervention.
|
Self-reported interviewer-administered Form 90 Substance Use interview developed for National Institute on Alcohol Abuse and Alcoholism (NIAAA) funded Project Match.
The Form 90 differentiates illicit drug use from prescribed drug use including marijuana.
|
Administered at baseline, and 3-, 6-, and 12-, 18-, and 24-months post intervention.
|
|
Shortened Inventory of Problems - Alcohol and Drugs (SIP-AD)
Time Frame: Administered at baseline, and 3-, 6-, and 12-, 18-, and 24-months post intervention.
|
The SIP-AD measures consequences related to impulse control and social responsibility, as well as physical, interpersonal, and intrapersonal domains with good psychometric properties.
|
Administered at baseline, and 3-, 6-, and 12-, 18-, and 24-months post intervention.
|
|
Presence of drugs of abuse
Time Frame: Administered at baseline, and 3-, 6-, and 12-, 18-, and 24-months post intervention.
|
One-step BMC ToxCup® Urine Test Kit Provides instant reading urine test for the presence or lack of detection of cannabinoids, amphetamines, methamphetamines, phencyclidine (PCP), cocaine/crack, and opiates. (Branan Medical Corp., Irvine, CA). Detection levels: Marijuana 50 ng/ml Cocaine 150 ng/ml Opiates 300 ng/ml Methamphetamine 500 ng/ml Ecstasy 500 ng/ml Phencyclidine 25 ng/ml Propoxyphene 300 ng/ml Benzodiazepines 300 ng/ml Barbiturates 300 ng/ml Methadone 300 ng/ml Buprenorphine 10 ng/ml Tricyclic Antidepressants 1000 ng/ml Oxycodone 100 ng/ml |
Administered at baseline, and 3-, 6-, and 12-, 18-, and 24-months post intervention.
|
|
Beck Depression Inventory II (BDI-II)
Time Frame: Administered at baseline, and 3-, 6-, and 12-, 18-, and 24-months post intervention.
|
The most frequently used self-report instrument to assess mood, cognitive and somatic aspects of depression.
The BDI-II has good psychometric properties.
Scores range from 0 - 63 with higher scores indicating more depressived symptoms and worse outcomes.
|
Administered at baseline, and 3-, 6-, and 12-, 18-, and 24-months post intervention.
|
|
Beck Anxiety Inventory (BAI)
Time Frame: Administered at baseline, and 3-, 6-, and 12-, 18-, and 24-months post intervention.
|
Used to assess current anxiety symptoms via 21 items, rated in intensity with scores ranging from 0-63.
It was developed to discriminate symptoms of anxiety from depressive symptoms, and has alpha coefficients ranging from 0.90-0.94.
Higher scores indicate more anxiety symptoms and worse outcomes.
|
Administered at baseline, and 3-, 6-, and 12-, 18-, and 24-months post intervention.
|
|
Short Form-12
Time Frame: Administered at baseline, and 3-, 6-, and 12-, 18-, and 24-months post intervention.
|
Standardized, internationally used instrument that provides a general measure of health status.The 12 items on the SF-12 are summarized in two weighted summary scales, and generate a mental health and physical health score.
Scores range from 1 -100.
Lower scores indicate poorer health.
Construct validity has been evaluated with adult users of a homeless day shelter
|
Administered at baseline, and 3-, 6-, and 12-, 18-, and 24-months post intervention.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Narcotic-Related Disorders
- Mental Disorders
- Chemically-Induced Disorders
- Behavior
- Opioid-Related Disorders
- Substance-Related Disorders
- Risk-Taking
- Health Services
- Health Care Facilities Workforce and Services
- Behavioral Disciplines and Activities
- Directive Counseling
- Counseling
- Mental Health Services
- Motivational Interviewing
Other Study ID Numbers
- 2023H0244
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
The proposed research for public-use data sharing will include three data types: survey data, stress biomarker data, and activity-space data. The final survey dataset will include self-reported demographic, behavioral, social (e.g. exposures to adversity, including homelessness, violence, incarceration, etc.) and health-related data (e.g. psychosocial measures, mental and physical health symptoms/disorders and diagnoses, health services).
The data will be deposited with the Inter-University Consortium for Political and Social Research (ICPSR), an NIH funded data repository supported by National Institute on Drug Abuse as a data repository. The data from all 300 participants will be available for the six time-points of collection, made available in ICPSR preferred formats (e.g., CSV, SAS, SPSS) and securely transferred to ICPSR. Identifying (individual and location data) and personal health information will NOT be shared to protect participant confidentiality.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Risk Behavior
-
Ohio State University Comprehensive Cancer CenterBreast Cancer Research FoundationRecruiting
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsCompletedRisk ReductionSouth Africa
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingBehavior, RiskUnited States
-
University of California, San FranciscoUniversity of MiamiCompletedRisk ReductionUnited States
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsCompleted
-
Bournemouth UniversityDorset HealthCare University NHS Foundation TrustWithdrawnRisk Behavior | Violence | Risk Behavior, Health
-
Hadassah Medical OrganizationCompletedHealth Behavior | Food Habits | Lifestyle Risk ReductionIsrael
-
Hadassah Medical OrganizationHebrew University of JerusalemNot yet recruitingHealth Behavior | Food Habits | Lifestyle Risk Reduction
-
Vivoptim SolutionsCompletedCardiovascular Risk | Lifestyle Risk Reduction | Cardiovascular Disease Prevention | Lifestyle (Sedentary Behavior and Physical Activity) | Health Behavior ChangeFrance
-
Colorado State UniversityUniversity of Colorado, Denver; United States Department of Agriculture (USDA) and other collaboratorsRecruitingMental Health Wellness | Lifestyle Risk Reduction | Family ResearchUnited States
Clinical Trials on Motivational Interviewing/Community Reinforcement Approach (MI/CRA)
-
University of New MexicoNational Institute on Drug Abuse (NIDA)Completed
-
Karolinska InstitutetRecruitingSubstance Use Disorders | Criminal BehaviorSweden
-
Ohio State UniversityNational Institute on Drug Abuse (NIDA)Completed
-
Kjeld AndersenUniversity of New Mexico; Addiction Research Unit, Technische Universität,... and other collaboratorsCompleted
-
Vanderbilt University Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedEnd Stage Renal Disease on DialysisUnited States
-
University of IowaCompletedSelf-efficacyUnited States
-
IrisZorgRadboud University Medical CenterTerminated
-
International Islamic University, IslamabadPakistan Institute of Living and LearningActive, not recruitingCannabis DependencePakistan
-
Chinese University of Hong KongThe University of Hong KongCompleted
-
University of Illinois at Urbana-ChampaignUniversity of WashingtonNot yet recruiting